Meanwhile, the accumulation and exploitation of metabolic pathways offer the “microenvironmental support” for immune suppression and the maintenance of inflammation, which ultimately work synergically to drive the tumor immune microenvironment into a suppressive state in KRAS-mutant tumors. This evidence concerns the gene KRAS and neoplasm.